Today’s episode is with the founders of Ignite Biomedical, Claudio Faria & Jake Nichols. These two men are career pharmacists and MBAs who have been involved in nearly every aspect of the trade - clinical practice, academia, and industry. Both with different specialties, they were united by a common mission that will change healthcare forever. In 2022 they founded Ignite, a company that invests in the discovery of algorithmic biomarkers through the utilization of Evolutionary Computation via Emerge® – the only quantitative artificial intelligence platform in Biopharma proprietary to their Joint Venture partner Liquid Biosciences. This technology will de-risk development candidates, give drug companies a more accurate representation of the market and deliver true value based care.
During the episode we talk about the state of healthcare and how we need massive changes in philosophy and approach to start advancing science. We get into the challenges of treatment non-response and how a 4 % success rate in any other industry would be unacceptable. They thoroughly explain how the tests they are developing have the potential to change medicine forever starting with inflammatory bowel disease, which they have already received analytical validation for. They further explain how the potential for this new approach is extremely vast and will open up doors for other discoveries.
Nothing gets me more excited than to see the potential for real change in our world. These guys are bringing it.
Connect with Jake, Claudio and Ignite
https://www.instagram.com/ignite_biomedical/
